May 23, 2013 9:32am EDT OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)
Apr 05, 2013 11:45am EDT OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology
Mar 07, 2013 8:30am EST RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets
Mar 01, 2013 8:16am EST OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa